HBx promotes hepatic lipid accumulation through upregulating FABP1 that involves HNF3β, C/EBPα, and PPARα in the development of HBV-induced NAFLD/FABP1. The gene discussed is FABP1; the disease is metabolic dysfunction-associated steatotic liver disease.